![Min-Chul Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Min-Chul Park
Direttore/Membro del Consiglio presso
ZyVersa Therapeutics Operating, Inc.
Patrimonio netto: - $ in data 30/06/2026
Profilo
Min-Chul Park is the founder of Tme Therapeutics, Inc. Current jobs include Director at ZyVersa Therapeutics Operating, Inc. and Assistant Professor at Inje University.
Former jobs include Chief Executive Officer & Director at Neomics Co., Ltd., Chief Executive Officer & Director at Curebio Therapeutics in 2022, Chief Executive Officer & Director at CURE BIO Co., Ltd. from 2020 to 2022, Independent Director at ZyVersa Therapeutics, Inc. from 2022 to 2026, and Senior Associate-Research at Medicinal Bioconvergence Research Center.
Education includes a doctorate from Seoul National University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/07/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Min-Chul Park
| Società | Posizione | Inizio |
|---|---|---|
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direttore/Membro del Consiglio | - |
Inje University
 Inje University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Min-Chul Park
| Società | Posizione | Fine |
|---|---|---|
| ZYVERSA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 08/07/2026 |
CURE BIO Co., Ltd.
 CURE BIO Co., Ltd. BiotechnologyHealth Technology Engages in research and development of medicines | Amministratore Delegato | 01/04/2022 |
Neomics Co., Ltd.
 Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer | Amministratore Delegato | 01/01/2017 |
Medicinal Bioconvergence Research Center | Corporate Officer/Principal | - |
Formazione di Min-Chul Park
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neomics Co., Ltd.
Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer | Health Technology |
Inje University
Inje University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CURE BIO Co., Ltd.
CURE BIO Co., Ltd. BiotechnologyHealth Technology Engages in research and development of medicines | Health Technology |
ZyVersa Therapeutics, Inc.
 ZyVersa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops product candidates in the areas of renal and inflammatory diseases | Health Technology |
Medicinal Bioconvergence Research Center |
